Assetmark Inc. Purchases 141 Shares of National Health Investors, Inc. (NYSE:NHI)

Assetmark Inc. increased its position in shares of National Health Investors, Inc. (NYSE:NHI) by 27.8% in the third quarter, Holdings Channel.com reports. The firm owned 648 shares of the real estate investment trust’s stock after purchasing an additional 141 shares during the quarter. Assetmark Inc.’s holdings in National Health Investors were worth $54,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. Easterly Investment Partners LLC purchased a new position in shares of National Health Investors during the third quarter valued at approximately $5,632,000. Robeco Institutional Asset Management B.V. purchased a new stake in National Health Investors in the third quarter worth $336,000. Van ECK Associates Corp lifted its position in shares of National Health Investors by 12.3% during the third quarter. Van ECK Associates Corp now owns 7,192 shares of the real estate investment trust’s stock worth $550,000 after purchasing an additional 788 shares during the last quarter. Harbor Capital Advisors Inc. purchased a new stake in shares of National Health Investors during the third quarter valued at $70,000. Finally, Stephens Inc. AR increased its stake in National Health Investors by 12.4% in the 3rd quarter. Stephens Inc. AR now owns 8,566 shares of the real estate investment trust’s stock worth $720,000 after buying an additional 945 shares during the period. 62.51% of the stock is currently owned by institutional investors.

National Health Investors Trading Down 0.7 %

NHI opened at $77.16 on Tuesday. The company has a current ratio of 10.29, a quick ratio of 10.29 and a debt-to-equity ratio of 0.92. The firm has a market cap of $3.50 billion, a price-to-earnings ratio of 26.52, a PEG ratio of 5.19 and a beta of 1.05. National Health Investors, Inc. has a 12 month low of $51.59 and a 12 month high of $86.13. The stock has a fifty day moving average price of $79.97 and a 200-day moving average price of $74.14.

National Health Investors (NYSE:NHI) last announced its earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 EPS for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.42). National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The firm had revenue of $63.32 million during the quarter, compared to the consensus estimate of $67.93 million. During the same quarter in the prior year, the firm posted $1.08 earnings per share. The business’s revenue for the quarter was up 1.7% compared to the same quarter last year. As a group, equities research analysts anticipate that National Health Investors, Inc. will post 4.42 earnings per share for the current fiscal year.

National Health Investors Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 29th. Stockholders of record on Tuesday, December 31st will be given a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a dividend yield of 4.67%. The ex-dividend date of this dividend is Tuesday, December 31st. National Health Investors’s payout ratio is presently 123.71%.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on NHI shares. StockNews.com cut shares of National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, October 15th. Bank of America assumed coverage on National Health Investors in a research note on Tuesday, September 24th. They issued a “buy” rating and a $92.00 price objective on the stock. Truist Financial lifted their target price on National Health Investors from $65.00 to $78.00 and gave the company a “hold” rating in a research report on Friday, August 30th. Finally, Wells Fargo & Company downgraded National Health Investors from an “overweight” rating to an “equal weight” rating and increased their price target for the stock from $81.00 to $86.00 in a research report on Tuesday, October 1st. Four research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $73.29.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.